Clinical trials: Disclosure
HIV
Pediatric HIV Disclosure Benefits Study (PhD-BS) - Sankofa 2
The purpose of this study is to conduct a pragmatic, stepped wedge cluster randomized trial in 12 HIV pediatric clinics in Ghana to determine effectiveness, health benefits, cost and implementation to inform scale-up and…
- Trial name
- NCT04791865
- Testing
- Disclosure intervention, Usual Care
- Where
- Ghana
- Volunteers
- 748 people
- Sponsor
- Boston University
Knowledge, Practice Nurse's Scope
Managing High-alert Medication Administration and Errors
High-alert medications are drugs that may lead to serious harm when they are wrongly administered to patients. Safe medication administration is the crucial role of nursing staff.
- Conditions
- Knowledge, Practice Nurse's Scope, Competence, Nurse's Role
- Trial name
- NCT06366607
- Testing
- high-alert medication administration
- Where
- Egypt
- Volunteers
- 300 people
- Sponsor
- Matrouh University
Adolescent Behavior, HIV
Adolescent Transition To Adult Care for HIV-infected Adolescents in Kenya
This study evaluates an adolescent transition package (ATP) to support HIV infected adolescents transitioning form pediatric/adolescent care to adult care.
- Conditions
- Adolescent Behavior, HIV, Transition, Adolescent Development
- Trial name
- ATTACH (NCT03574129)
- Testing
- Adolescent Transition Package
- Where
- Kenya
- Volunteers
- 1,095 people
- Sponsor
- University of Washington
HIV
SANKOFA Pediatric HIV Disclosure Intervention
A culturally-relevant, theoretically and empirically sound, patient-centered, standardized disclosure intervention that can be integrated into routine clinical pediatric HIV care has potential to prevent transmission and improve…
- Trial name
- NCT01701635
- Testing
- Disclosure intervention, usual care
- Where
- 2 sites in Ghana
- Volunteers
- 446 people
- Sponsor
- Yale University
Error Disclosure, Diagnoses Disease
A Priori Diagnosis and Diagnostic Errors
This is a prospective randomized single-blind simulator-based trial. 156 4th year medical students were randomised to receive one of three different suspected diagnoses of a pre-treating physician (no diagnosis, myocardial…
- Conditions
- Error Disclosure, Diagnoses Disease, Simulation of Physical Illness
- Trial name
- NCT04659265
- Testing
- Suspected diagnosis of a pre-treating physician
- Where
- Switzerland
- Volunteers
- 156 people, healthy volunteers welcome
- Sponsor
- University Hospital, Basel, Switzerland
Autism Spectrum Disorder
Diagnosis Disclosure Support for Caregivers of Children With Autism
The purpose of this randomized controlled pilot study is to develop and evaluate an online diagnosis disclosure support intervention for caregivers of 7- to 12-year-old children with autism spectrum disorder (ASD) in South Korea.
- Trial name
- NCT07328438
- Testing
- SHARE : Supporting Honest Autism Recognition and Education, One-session seminar
- Volunteers
- 40 people
- Sponsor
- Korea University
Sickle Cell Trait
Increasing Documentation and Disclosure of Sickle Cell Trait Status: An Implementation Science Approach
The hemoglobinopathy newborn screen (NBS) performed on all neonates in the U.S. allows for early life-saving medical care for infants with sickle cell disease (SCD), an autosomal recessive genetic disorder.
- Trial name
- NCT05387564
- Testing
- SCT Documentation and Disclosure Toolkit (SCT-DD)
- Where
- United States
- Volunteers
- 114 people
- Sponsor
- Nemours Children's Clinic
Secrecy Versus Disclosure Among Adolescents With Mental Illness
Honest Open Proud for Adolescents With Mental Illness
The purpose of the study is to evaluate the efficacy of the group-based intervention 'Honest Open Proud' among adolescents with mental illness.
- Trial name
- NCT02751229
- Testing
- Honest Open Proud (HOP)
- Where
- 5 sites in United States, Germany
- Volunteers
- 100 people
- Sponsor
- University of Ulm
HIV
Maternal HIV: Trial to Assist Disclosure to Children
The purpose of this Collaborative R01, under Program Announcement PAR-09-153, is to conduct a full-scale trial of an intervention to assist mothers living with HIV (MLH) with disclosing their serostatus to their young age 6 - 14…
- Trial name
- TRACK II (NCT01922206)
- Testing
- TRACK Intervention
- Where
- United States
- Volunteers
- 362 people
- Sponsor
- Georgia State University
Other Diseases or Conditions | Patient
Efficacy of Gastric Biopsy for Culture and Antibiotic Sensitivity Assessment
Gastric biopsies will be taken to compare different methods of H.pylori disclosure.Standard methods will be compared to culture.
- Trial name
- NCT01414829
- Testing
- Gastroscopy
- Sponsor
- The Baruch Padeh Medical Center, Poriya